Medication Changes Prior to Hospitalization for Obstructive Lung Disease: A Case-Crossover Study

Abstract

Spanish

Background:

Hospitalizations have always been seen as a solid outcome parameter in pharmacoepidemiology. However, the period leading to hospitalization and prehospital management of the patient are equally important.

Objective:

To evaluate medication changes in the period prior to hospitalization for obstructive lung disease and to quantify the association between medication use and the risk of hospitalization.

Methods:

We conducted a case-crossover study using the PHARMO record linkage system, which contains drug dispensing data from community pharmacies and hospital admission data. Patients included in the study were adults hospitalized for obstructive lung disease between 2005 and 2007. The index date of the case period was the date of hospitalization, and control moments were set at 3, 6, 9, and 12 months before admission. For each patient, all prescriptions prior to the date of hospitalization were identified. Medication use was ascertained in a 90-day time window prior to each case or control moment.

Results:

We identified 1481 patients who were hospitalized for obstructive lung disease. It appeared that respiratory medication use increased in the 90 days prior to hospitalization. Hospitalization was associated with the use of 3 or more respiratory drugs (OR 2.2; 95% CI 1.8 to 2.8), systemic glucocorticoids (OR 4.5; 95% CI 3.8 to 5.4), and antibiotics (OR 3.1; 95% CI 2.7 to 3.6).

Conclusions:

The use of systemic glucocorticoids, antibiotics, and other respiratory drugs increased prior to hospitalization for obstructive lung disease. These results could be indicative of the development and/or treatment of an exacerbation. There is a need for markers to detect exacerbations in an early phase in order to start treatment as early as possible and possibly prevent hospitalizations for obstructive lung disease.

Keywords

case-crossover study glucocorticoids hospitalization obstructive lung disease

Get full access to this article

View all access options for this article.

References

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. 2008. www.goldcopd.org (accessed 2009 Sept 28).

Global Initiative for Asthma. Global strategy for asthma management and prevention. 2008. www.ginasthma.org (accessed 2009 Sept 28).

Halbert

, Natoli

, Gano

, Badamgarav

, Buist

, Mannino

. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28:523–32. DOI 10.1183/09031936.06.00124605

Siva

, Green

, Brightling

. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007; 29:906–13. DOI 10.1183/09031936.00146306

Shireman

, Heaton

, Gay

, Cluxton

, Moomaw

. Relationship between asthma drug therapy patterns and healthcare utilization. Ann Pharmacother 2002; 36:557–64. DOI 10.1345/aph.1A067

McKnight

, Scott

, Menzies

, Bourbeau

, Biais

, Lemière

. A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol 2005; 58:206–8. DOI 10.1016/j.jclinepi.2004.08.006

Biais

, Ernst

, Boivin

, Suissa

. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998; 158:126–32. http://ajrccm.atsjournals.org.proxy.library.uu.nl/cgi/reprint/158/1/126

Ekberg-Aronsson

, Lofdahl

, Nilsson

, Lofdahl

, Nilsson

. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease–-a population-based study. Respir Med 2008; 102:109–20. DOI 10.1016/j.rmed.2007.07.028

Geelhoed

, Brameld

, Holman

, Thompson

. Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends. Intern Med J 2007; 37:87–94. DOI 10.1111/j.1445-5994.2007.01240.x

10.

Thomson

, Chaudhuri

. Identification and management of adults with asthma prone to exacerbations: can we do better? BMC Pulm Med 2008; 8:27. DOI 10.1186/1471-2466-8-27

11.

Gerrits

, Herings

, Leufkens

, Lammers

. Asthma exacerbations during first therapy with long acting beta 2-agonists. Pharm World Sci 1999; 21:116–9. DOI 10.1023/A:1008618700934

12.

Van Ganse

, Van der Linden

, Leufkens

, Herings

, Vincken

, Ernst

. Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance. Eur Respir J 1995; 8:1856–60. DOI 10.1183/09031936.95.08111856

13.

Boyter

, Steinke

. Changes in prescribing of inhaled corticosteroids (1999–2002) in Scotland. Pharmacoepidemiol Drug Saf 2005; 14:203–9. DOI 10.1002/pds.1054

14.

Simpson

, Matusiewicz

, Brown

. Emergency pre-hospital management of patients admitted with acute asthma. Thorax 2000; 55:97–101. DOI 10.1136/thorax.55.2.97

15.

Velthove

, Souverein

, van Solinge

, Leufkens

, Lammers

. Effects of corticosteroid use on readmission in obstructive lung disease. Respir Med. Epub 23 Sept 2009. DOI 10.1016/j.rmed.2009.08.014

16.

Almagro

, Barreiro

, Ochoa de Echaguen

. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 2006; 73:311–7. DOI 10.1159/000088092

17.

Gudmundsson

, Gislason

, Janson

. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26:414–9. DOI 10.1183/09031936.05.00078504

18.

Schneeweiss

, Sturmer

, Maclure

. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf 1997; 6(suppl 3):S51–9. DOI 10.1002/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.3.CO;2-J

19.

Barbone

, McMahon

, Davey

. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352:1331–6. DOI 10.1016/S0140-6736(98)04087-2

20.

Redelmeier

, Tibshirani

. Association between cellular-telephone calls and motor vehicle collisions. N Engl J Med 1997; 336:453–8. DOI 10.1056/NEJM199702133360701

21.

Handoko

, Zwart-Van Rijkom

, Hermens

, Souverein

, Egberts

. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study. Pharmacoepidemiol Drug Saf 2007; 16:189–96. DOI 10.1002/pds.1333

22.

Lazarou

, Pomeranz

, Corey

. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279:1200–5. DOI 10.1001/jama.279.15.1200

23.

Kongkaew

, Noyce

, Ashcroft

. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008; 42:1017–25. Epub 1 Jul 2008. DOI 10.1345/aph.1L037

24.

Leendertse

, Egberts

, Stoker

, Van den Bemt

. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168:1890–6. DOI 10.1001/archinternmed.2008.3

25.

Peyriere

, Cassan

, Floutard

. Adverse drug events associated with hospital admission. Ann Pharmacother 2003; 37:5–11. DOI 10.1345/aph.1C126

26.

Herings

, Bakker

, Stricker

, Nap

. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 1992; 46:136–40. DOI 10.1136/jech.46.2.136

27.

Gerrits

, Herings

, Leufkens

, Lammers

. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 21:795–8. DOI 10.1183/09031936.03.00063402

28.

Maclure

, Mittleman

. Should we use a case-crossover design? Annu Rev Public Health 2000; 21:193–221. DOI 10.1146/annurev.publ-health.21.1.193

29.

Blais

, Suissa

, Boivin

, Ernst

. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 1998; 53:1025–9. DOI 10.1136/thx.53.12.1025

30.

Roede

, Bresser

, Bindels

. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax 2008; 63:968–73. DOI 10.1136/thx.2008.095349

31.

Ten Brinke

, Sterk

, Masclee

. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir.J 2005; 26:812–8. DOI 10.1183/09031936.05.00037905

32.

Malfertheiner

, Hallerback

. Clinical manifestations and complications of gastroesophageal reflux disease (GERD). Int J Clin Pract 2005; 59:346–55. DOI 10.1111/j.1742-1241.2005.00370.x

33.

Pistelli

, Lange

, Miller

. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur Respir J Suppl 2003; 40:10s–4s. DOI 10.1183/09031936.03.00403403

34.

Frey

, Suki

. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet 2008; 372:1088–99. DOI 10.1016/S0140-6736(08)61450-6

35.

In't Veen

, Smits

, Hiemstra

, Zwinderman

, Sterk

, Bel

. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999; 160:93–9. http://ajrccm.atsjournals.org/cgi/reprint/160/1/93

36.

Velthove

, Bracke

, Souverein

. Identification of exacerbations in obstructive lung disease through biomarkers. Biomarkers 2009; 14:523–8. DOI 10.1080/13547500903150763

37.

Stuffken

, Heerdink

, de Koning

FHP

, Souverein

, Egberts

ACG

. Association between hospitalization and discontinuity of medication therapy used in the community setting in the Netherlands. Ann Pharmacother 2008; 42:933–9. Epub 10 Jun 2008. DOI 10.1345/aph.1L062

38.

Tovar

, Gums

. Monitoring pulmonary function in asthma and COPD: point-of-care testing. Ann Pharmacother 2004; 38:126–33. Epub 5 Dec 2003. DOI 10.1345/aph.1D230

39.

Jack

, Chetty

, Anthony

. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med 2009; 150:178–87. www.pubmedcentral.nih.gov/picrender.fcgi?artid=2738592&blobtype=pdf

40.

Karapinar-Carkit

, Borgsteede

, Zoer

, Smit

, Egberts

ACG

, van den Bemt

PMLA

. Effect of medication reconciliation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. Ann Pharmacother 2009; 43:1001–10. Epub 2 Jun 2009. DOI 10.1345/aph.1L597